Autopsy report · NCT01629511
Allogeneic Stem Cell Transplant for CLL
Cause of deathNo reason given
Life of this trial
- Registered 5 months before it started.
- Ran for about 5 years 5 months before it stopped.
- 15 participants enrolled.
- Results were posted on the registry 1 year 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Conditions
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Richter Syndrome
- Interventions
- Allogeneic Hematopoietic Stem Cell Transplantation; Anti-Thymocyte Globulin; Busulfan; Clofarabine; Filgrastim; Gemcitabine
- Participants
- 15
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.